These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


329 related items for PubMed ID: 10448934

  • 1. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system.
    Griffin G, Wray EJ, Tao Q, McAllister SD, Rorrer WK, Aung MM, Martin BR, Abood ME.
    Eur J Pharmacol; 1999 Jul 14; 377(1):117-25. PubMed ID: 10448934
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of SR141716A on G-protein activation in rat brain.
    Sim-Selley LJ, Brunk LK, Selley DE.
    Eur J Pharmacol; 2001 Mar 02; 414(2-3):135-43. PubMed ID: 11239913
    [Abstract] [Full Text] [Related]

  • 3. Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor.
    Gouldson P, Calandra B, Legoux P, Kernéis A, Rinaldi-Carmona M, Barth F, Le Fur G, Ferrara P, Shire D.
    Eur J Pharmacol; 2000 Jul 28; 401(1):17-25. PubMed ID: 10915832
    [Abstract] [Full Text] [Related]

  • 4. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
    Izzo AA, Mascolo N, Pinto L, Capasso R, Capasso F.
    Eur J Pharmacol; 1999 Nov 12; 384(1):37-42. PubMed ID: 10611417
    [Abstract] [Full Text] [Related]

  • 5. Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630.
    Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A, Pertwee RG.
    Br J Pharmacol; 1999 Feb 12; 126(3):665-72. PubMed ID: 10188977
    [Abstract] [Full Text] [Related]

  • 6. Cannabinoid receptor agonists inhibit Ca(2+) influx to synaptosomes from rat brain.
    Yoshihara S, Morimoto H, Ohori M, Yamada Y, Abe T, Arisaka O.
    Pharmacology; 2006 Feb 12; 76(4):157-62. PubMed ID: 16446560
    [Abstract] [Full Text] [Related]

  • 7. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L, Howlett AC, Mukhopadhyay S.
    J Pharmacol Exp Ther; 2007 Jun 12; 321(3):930-7. PubMed ID: 17379772
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M, McCreary AC, Przegaliński E, Filip M.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):96-106. PubMed ID: 16730696
    [Abstract] [Full Text] [Related]

  • 9. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice.
    Smith SR, Terminelli C, Denhardt G.
    J Pharmacol Exp Ther; 2000 Apr 01; 293(1):136-50. PubMed ID: 10734163
    [Abstract] [Full Text] [Related]

  • 10. Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands.
    Smith SR, Terminelli C, Denhardt G.
    Eur J Pharmacol; 2001 Aug 03; 425(1):73-83. PubMed ID: 11672577
    [Abstract] [Full Text] [Related]

  • 11. Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.
    Ross RA, Brockie HC, Fernando SR, Saha B, Razdan RK, Pertwee RG.
    Br J Pharmacol; 1998 Nov 03; 125(6):1345-51. PubMed ID: 9863666
    [Abstract] [Full Text] [Related]

  • 12. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
    Paugh SW, Cassidy MP, He H, Milstien S, Sim-Selley LJ, Spiegel S, Selley DE.
    Mol Pharmacol; 2006 Jul 03; 70(1):41-50. PubMed ID: 16571654
    [Abstract] [Full Text] [Related]

  • 13. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
    Liu Q, Bhat M, Bowen WD, Cheng J.
    J Pharmacol Exp Ther; 2009 Dec 03; 331(3):1062-70. PubMed ID: 19752241
    [Abstract] [Full Text] [Related]

  • 14. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR.
    J Pharmacol Exp Ther; 2006 Dec 03; 319(3):1211-8. PubMed ID: 16943255
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor.
    Ruiu S, Pinna GA, Marchese G, Mussinu JM, Saba P, Tambaro S, Casti P, Vargiu R, Pani L.
    J Pharmacol Exp Ther; 2003 Jul 03; 306(1):363-70. PubMed ID: 12663689
    [Abstract] [Full Text] [Related]

  • 16. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.
    Hasanein P, Parviz M, Keshavarz M, Javanmardi K.
    Clin Exp Pharmacol Physiol; 2007 Jul 03; 34(5-6):439-49. PubMed ID: 17439413
    [Abstract] [Full Text] [Related]

  • 17. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.
    Meschler JP, Kraichely DM, Wilken GH, Howlett AC.
    Biochem Pharmacol; 2000 Nov 01; 60(9):1315-23. PubMed ID: 11008125
    [Abstract] [Full Text] [Related]

  • 18. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
    Thomas A, Baillie GL, Phillips AM, Razdan RK, Ross RA, Pertwee RG.
    Br J Pharmacol; 2007 Mar 01; 150(5):613-23. PubMed ID: 17245363
    [Abstract] [Full Text] [Related]

  • 19. A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide.
    Benamar K, Yondorf M, Meissler JJ, Geller EB, Tallarida RJ, Eisenstein TK, Adler MW.
    J Pharmacol Exp Ther; 2007 Mar 01; 320(3):1127-33. PubMed ID: 17194800
    [Abstract] [Full Text] [Related]

  • 20. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
    Zhang CQ, Wu HJ, Wang SY, Yin S, Lu XJ, Miao Y, Wang XH, Yang XL, Wang Z.
    Neuroscience; 2013 Dec 03; 253():183-93. PubMed ID: 24013008
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.